NVCR
Ticker
Novocure Ltd
Company
Devices
Industry
Healthcare
Sector
Financial Ratio Analysis
2013
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”49.5%113.6%150.5%113.6%40.1%41.6%40.7%8.2%0.5%-5.3%18.8%β€”11.2%
Revenue Growth QoQ
β€”49.5%113.6%150.5%113.6%40.1%41.6%40.7%8.2%0.5%-5.3%18.8%β€”β€”
Gross Margin
32.3%35.2%37.7%44.2%68.6%67.7%74.8%78.5%78.5%78.6%74.8%77.3%β€”75.4%
EBITDA Margin
-610.5%-504.8%-304.8%-132.3%-17.9%-9.9%2.1%8.0%-6.4%-14.7%-43.6%-26.3%β€”-25.4%
Operating Margin
-622.3%-517.5%-314.3%-139.1%-22.2%-13.6%-0.3%6.1%-8.3%-16.6%-45.7%-28.2%β€”-27.5%
Profit Margin
-746.9%-520.9%-337.2%-159.1%-34.8%-25.6%-2.1%4.0%-10.9%-17.2%-40.6%-27.9%β€”-27.7%
FCF / EBITDA
89.1%97.9%109.2%114.2%128.0%34.8%213.8%212.8%-171.9%-12.0%45.3%43.5%β€”39.9%